Literature DB >> 30874823

Impact of macrolide therapy in critically ill patients with acute respiratory failure: a desirability of outcome ranking analysis to investigate the OUTCOMEREA database.

Stéphanie Pons1, Jean-François Timsit2,3, Stéphane Ruckly3, Carole Schwebel4, Laurent Papazian5, Elie Azoulay6, Jean Reignier7, Lara Zafrani8,9.   

Abstract

Entities:  

Year:  2019        PMID： 30874823     DOI： 10.1007/s00134-019-05586-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia.

Authors:  Daniele Roberto Giacobbe; Alessio Signori; Mario Tumbarello; Riccardo Ungaro; Giovanni Sarteschi; Elisa Furfaro; Malgorzata Mikulska; Maurizio Sanguinetti; Brunella Posteraro; Angela Raffaella Losito; Gennaro De Pascale; Valerio Del Bono; Claudio Viscoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-30       Impact factor: 3.267

2.  Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.

Authors:  Cristina Cigana; Baroukh Maurice Assael; Paola Melotti
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

3.  Macrolide antibiotics and survival in patients with acute lung injury.

Authors:  Allan J Walkey; Renda S Wiener
Journal:  Chest       Date:  2011-11-23       Impact factor: 9.410

4.  Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia.

Authors:  Evangelos J Giamarellos-Bourboulis; Jean-Claude Pechère; Christina Routsi; Diamantis Plachouras; Spyridon Kollias; Maria Raftogiannis; Dimitrios Zervakis; Fotini Baziaka; Apostolos Koronaios; Anastasia Antonopoulou; Vassiliki Markaki; Pantelis Koutoukas; Evangelos Papadomichelakis; Thomas Tsaganos; Apostolos Armaganidis; Vassilios Koussoulas; Anastasia Kotanidou; Charis Roussos; Helen Giamarellou
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

5.  Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis.

Authors:  Kodai Kawamura; Kazuya Ichikado; Makoto Takaki; Yoshihiko Sakata; Yuko Yasuda; Naoki Shingu; Aoi Tanaka; Jyunpei Hisanaga; Yoshitomo Eguchi; Keisuke Anan; Tatuya Nitawaki; Moritaka Suga
Journal:  Springerplus       Date:  2016-07-28
  5 in total
  3 in total

1.  Interpreting desirability of outcome ranking (DOOR) analyses in observational studies in infectious diseases: caution still needed.

Authors:  Daniele Roberto Giacobbe; Alessio Signori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-06-17       Impact factor: 3.267

2.  Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation.

Authors:  Tom D Y Reijnders; Hessel Peters-Sengers; Lonneke A van Vught; Fabrice Uhel; Marc J M Bonten; Olaf L Cremer; Marcus J Schultz; Martijn M Stuiver; Tom van der Poll
Journal:  Crit Care       Date:  2022-05-24       Impact factor: 19.334

3.  Immunomodulation of endothelial cells induced by macrolide therapy in a model of septic stimulation.

Authors:  Stéphanie Pons; Eden Arrii; Marine Arnaud; Maud Loiselle; Juliette Ferry; Manel Nouacer; Julien Lion; Shannon Cohen; Nuala Mooney; Lara Zafrani
Journal:  Immun Inflamm Dis       Date:  2021-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.